NEW YORK – Bruker said on Wednesday that it has acquired a proteomics software platform from proteomics software firm Integrated Proteomics Applications.
Called the Integrated Proteomics Pipeline (IP2), the platform provides scalable and GPU-based search engine capabilities that Bruker said will enable faster data processing and better use of collision cross section data generated by the ion mobility portion of its timsTOF mass spectrometry system.
Integrated Proteomics Applications is a spinout from the lab of John Yates III, a professor at the Scripps Research Institute. As part of the acquisition, Robin Park, a cofounder of the company, is joining Bruker to head a new San Diego, California-based bioinformatics team that will focus on protein and data science.
"Partnering with the IP2 team and the Yates Lab provides an excellent opportunity to enhance Bruker’s bioinformatics capabilities in support of 4D-Proteomics," Rohan Thakur, Bruker’s executive VP for life science mass spectrometry, said in a statement. "High-throughput proteomics requires unprecedented search engine performance, including the need for low false discovery rates with very large datasets. This will benefit the proteomics research and translational medical community."
"We are very pleased to partner with Bruker in enabling a CCS-aware bioinformatics platform," Yates said. "Innovative software tools are a necessity to address unanswered biological questions with mass spectrometry. The trapped ion mobility functionality and the robustness of the timsTOF Pro offer unique bottom-up proteomics capabilities that can be effectively used to study many diseases."
Financial and other terms of the deal were not disclosed.